Table of contents
The new item-level traceability requirements of the U.S. Drug Supply Chain Security Act (DSCSA)—which take effect starting on November 27, 2023—introduce significant complexity and industry-wide challenges compared to the previous lot-level traceability mandate.
Among the new requirements, trade partners must ensure that Transaction Information with serialized product identifiers and Transaction Statements are provided for each unit of product that they receive—and that data must be exchanged in a secure, electronic, and interoperable manner.
TraceLink Product Track for Pharmaceutical Manufacturers provides compliance data management, operational process support, and supply chain data exchange capabilities for DSCSA compliance. With Product Track, pharmaceutical manufacturers are empowered to securely create, manage, and seamlessly exchange compliance data with supply chain trading partners. Read our new solution brief to learn about the key capabilities and benefits Product Track provides to Pharmaceutical Manufacturers, including:
- Fastest: With more than 290,000 members, all or most of your trading partners are already fully pre-integrated into the TraceLink network.
- Lowest TCO: Purpose-built solutions on the network provide complete end-to-end serialization traceability, interoperable data exchange, and product verification at the lowest total cost of ownership.
- Better: The TraceLink network and DSCSA compliance solutions are built on a highly scalable cloud platform to process data-intensive transactions at no additional cost.
- Future Proof: Continuous investment in network solutions for supply network orchestration, artificial intelligence, and multienterprise integration extends value beyond serialization and compliance.
Learn how TraceLink Track and Trace for Pharmaceutical Manufacturers enables you to reduce costs, improve operational efficiency, and improve patient outcomes.
